
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Recipient : VALANX Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement
VALANX Biotech And Fina Biosolutions Launch ClickCRM for Vaccine R&D
Details : The licensing agreement will commercialize ready-to-conjugate vaccine carrier protein CRM197 enabling rapid development of conjugate vaccines such as the pneumococcal and meningococcal vaccines.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 29, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Recipient : VALANX Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement
